Möller B - Search Results

1

Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors.

Nissen MJ, Möller B, Ciurea A, Mueller RB, Zueger P, Schulz M, Ganz F, Scherer A, Papagiannoulis E, Hügle T. Nissen MJ, et al. Among authors: moller b. Arthritis Res Ther. 2021 Jun 9;23(1):165. doi: 10.1186/s13075-021-02534-7. Arthritis Res Ther. 2021. PMID: 34107999 Free PMC article.

2

The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients.

Seitz M, Wirthmüller U, Möller B, Villiger PM. Seitz M, et al. Among authors: moller b. Rheumatology (Oxford). 2007 Jan;46(1):93-6. doi: 10.1093/rheumatology/kel175. Epub 2006 May 23. Rheumatology (Oxford). 2007. PMID: 16720636

3

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.

Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis. Finckh A, et al. Among authors: moller b. Arthritis Rheum. 2007 May;56(5):1417-23. doi: 10.1002/art.22520. Arthritis Rheum. 2007. PMID: 17469098 Free article.

4

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

Finckh A, Ciurea A, Brulhart L, Möller B, Walker UA, Courvoisier D, Kyburz D, Dudler J, Gabay C; Arthritis. Finckh A, et al. Among authors: moller b. Ann Rheum Dis. 2010 Feb;69(2):387-93. doi: 10.1136/ard.2008.105064. Epub 2009 May 4. Ann Rheum Dis. 2010. PMID: 19416802 Free PMC article.

5

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists.

Finckh A, Möller B, Dudler J, Walker UA, Kyburz D, Gabay C; physicians of the Swiss Clinical Quality Management for Rheumatoid Arthritis; physicians of SCQM-RA. Finckh A, et al. Among authors: moller b. Ann Rheum Dis. 2012 Oct;71(10):1680-5. doi: 10.1136/annrheumdis-2011-201016. Epub 2012 Mar 14. Ann Rheum Dis. 2012. PMID: 22419773 Free PMC article.

6

Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study.

Möller B, Scherer A, Förger F, Villiger PM, Finckh A; Swiss Clinical Quality Management Program for Rheumatic Diseases. Möller B, et al. Ann Rheum Dis. 2014 Apr;73(4):691-6. doi: 10.1136/annrheumdis-2012-202709. Epub 2013 Mar 16. Ann Rheum Dis. 2014. PMID: 23505235 Free PMC article.

7

Ultrasound evaluation of synovitis in RA: correlation with clinical disease activity and sensitivity to change in an observational cohort study.

Zufferey P, Brulhart L, Tamborrini G, Finckh A, Scherer A, Moller B, Ziswiler HR. Zufferey P, et al. Among authors: moller b. Joint Bone Spine. 2014 May;81(3):222-7. doi: 10.1016/j.jbspin.2013.08.006. Epub 2013 Nov 5. Joint Bone Spine. 2014. PMID: 24210684

8

Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study.

Möller B, Pruijm M, Adler S, Scherer A, Villiger PM, Finckh A; Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) Foundation, CH-8048 Zurich, Switzerland. Möller B, et al. Ann Rheum Dis. 2015 Apr;74(4):718-23. doi: 10.1136/annrheumdis-2013-204078. Epub 2013 Dec 19. Ann Rheum Dis. 2015. PMID: 24356672

9

Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study.

Zufferey P, Möller B, Brulhart L, Tamborrini G, Scherer A, Finckh A, Ziswiler HR. Zufferey P, et al. Among authors: moller b. Joint Bone Spine. 2014 Oct;81(5):426-32. doi: 10.1016/j.jbspin.2014.04.014. Epub 2014 Jun 20. Joint Bone Spine. 2014. PMID: 24956986

10

Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK).

Mueller RB, Gengenbacher M, Richter S, Dudler J, Möller B, von Kempis J. Mueller RB, et al. Among authors: moller b. Arthritis Res Ther. 2016 Apr 14;18:88. doi: 10.1186/s13075-016-0985-2. Arthritis Res Ther. 2016. PMID: 27074795 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,192 results

Search Page

Filters